Riker Lauren Bullaro sold ~$18M in Pacira BioSciences, Inc. stock
Pacira BioSciences, Inc. (PCRX) · Vice President, Finance · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
-13.7%vs SPY +8.1%
Trade Details · Public SEC Filing
Insider
Riker Lauren Bullaro
Role
Vice President, Finance
Transaction
Open-Market Sale
Approx. Value
~$18M
Trade Date
Mar 1, 2021
Company
Pacira BioSciences, Inc.
Ticker
PCRXSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$18M sale
Trades over $1M are rare. When insiders put this much of their own money on the line, they tend to have high conviction in their company's direction.
Vice President, Finance
Senior executives have visibility into their division's pipeline and company health. Their trades carry weight because they understand the business from the inside.
5 insiders traded in the same window
When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.
-13.7% in 90 days (S&P 500: +8.1%)
This trade underperformed the S&P 500 by 21.8 percentage points. Not every insider trade wins. We track all of them so you can focus on the insiders with the best records.
How good is Riker Lauren Bullaro at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
Riker Lauren Bullaro wasn't the only one selling.
5 insiders at Pacira BioSciences, Inc. traded within the same 30-day window.
See who else bought · FreeOn March 1, 2021, Riker Lauren Bullaro — Vice President, Finance of Pacira BioSciences, Inc. — filed a Form 4 with the SEC disclosing an open-market sale of approximately ~$18M in Pacira BioSciences, Inc. (PCRX) stock.
This transaction was part of a cluster — 5 insiders at Pacira BioSciences, Inc. made open-market sales within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, PCRX returned -13.7% versus +8.1% for the S&P 500 over the same period.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Riker Lauren Bullaro trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
More PCRX Insider Activity
Lee Frank D.
Aug 12, 2024
~$257K
VS
REINHARDT MAX
Jun 5, 2023
~$1.3M
VS
REINHARDT MAX
Jun 6, 2022
~$2.1M
VS
Riker Lauren Bullaro
Mar 1, 2022
~$1.3M
STRONG
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free